What is OS Therapies's debt-to-assets?

OS Therapies (OSTX) reported debt-to-assets of 2.7× in Q1 2026.

What does debt-to-assets mean?

Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.

OS Therapies OSTX Debt-to-assets

Debt-to-assets at other companies

ImmunomeIMNM

0×0.0×

Avalo TherapeuticsAVTX

0×0.0×

Arcus BiosciencesRCUS

0.1×+0.1×

ImmunityBio, Inc.IBRX

0.7×-0.4×

WHW

Whitehawk Therapeutics, Inc. Common StockWHWK

0×0.0×

Other financials

Income statement

See full

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

See full

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

See full

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

See full

Market cap$84.62M+65.5%

Enterprise value$103.7M—

Returns & leverage

See full

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Calculated from OS Therapies’s reported figures.

total debt/total assets=2.7×

Based on the most recent quarter.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OS Therapies's debt-to-assets?: OS Therapies (OSTX) reported debt-to-assets of 2.7× in Q1 2026.
What does debt-to-assets mean?: Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.